methotrexate has been researched along with Cardiotoxicity in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel All, MO; Abdelaleem, OO; Abdelmeguid, EA; Eldosoki, DE; Elsayed, RM; Mahmoud, RH; Mohammed, MA; Morsi, EM; Said, ES | 1 |
| Borawska, A; Dabrowska-Iwanicka, A; Domanska-Czyz, K; Druzd-Sitek, A; Konecki, R; Lampka, E; Lapinska, G; Osiadacz, W; Osowiecki, M; Ostrowska, B; Paszkiewicz-Kozik, E; Popławska, L; Romejko-Jarosinska, J; Rymkiewicz, G; Smorczewska, M; Swierkowska, M; Tajer, J; Targonski, L; Walewski, J | 1 |
| Flynn, B; Haeger-Overstreet, K; Shah, S | 1 |
| Dogan, Z; Durmus, S; Ergun, DD; Gelisgen, R; Sahin, H; Senturk, GE; Senyigit, A; Uzun, H | 1 |
| Aalders, K; Bartlett, JMS; Biganzoli, L; Bogaerts, J; Cameron, D; De Valk, B; Khaled, H; Marreaud, S; Tryfonidis, K; Vermorken, J; Welnicka-Jaskiewicz, M | 1 |
| Holt, GE; Lipshultz, ER; Lipshultz, SE; Ramasamy, R; Yechieli, R | 1 |
| Arcari, A; Centurioni, R; Evangelista, A; Freilone, R; Ladetto, M; Liberati, AM; Luminari, S; Massidda, S; Merli, F; Musuraca, G; Nassi, L; Patti, C; Pavone, V; Peli, A; Pulsoni, A; Re, A; Salvi, F; Spina, M; Stelitano, C; Tani, M; Tucci, A; Volpetti, S; Zanni, M | 1 |
| Gad, A; Hafez, E; Tousson, E; Zaki, S | 1 |
2 trial(s) available for methotrexate and Cardiotoxicity
| Article | Year |
|---|---|
Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiotoxicity; Cyclophosphamide; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Heart; Humans; Methotrexate; Neoplasm Metastasis; Receptor, ErbB-2; Trastuzumab | 2017 |
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL).
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Carmustine; Combined Modality Therapy; Female; Heart Diseases; Hodgkin Disease; Humans; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prognosis; Recurrence; Remission Induction; Survival Analysis; Teniposide; Treatment Outcome | 2019 |
6 other study(ies) available for methotrexate and Cardiotoxicity
| Article | Year |
|---|---|
Assessment of the cardioprotective effect of liraglutide on methotrexate induced cardiac dysfunction through suppression of inflammation and enhancement of angiogenesis in rats.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antioxidants; Cardiotonic Agents; Cardiotoxicity; Down-Regulation; Hypoglycemic Agents; Inflammation; Liraglutide; Male; Methotrexate; Neovascularization, Physiologic; Rats; Up-Regulation; Vascular Endothelial Growth Factor A | 2021 |
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Rituximab; Vincristine | 2022 |
Methotrexate-induced acute cardiotoxicity requiring veno-arterial extracorporeal membrane oxygenation support: a case report.
Topics: Cardiotoxicity; Extracorporeal Membrane Oxygenation; Heart Failure; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Stroke Volume; Ventricular Function, Left | 2022 |
Empagliflozin and sacubitril/valsartan reverse methotrexate cardiotoxicity by repressing oxidative stress and hypoxia in heart embryonic H9c2 cardiomyocytes - the role of morphology of mitochondria observed on electron microscopy.
Topics: Animals; Antioxidants; Cardiotoxicity; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Methotrexate; Microscopy, Electron; Mitochondria; Myocytes, Cardiac; Oxidants; Oxidative Stress; Rats; Valsartan | 2023 |
Fertility, Cardiac, and Orthopedic Challenges in Survivors of Adult and Childhood Sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Cancer Survivors; Cardiotoxicity; Child; Cisplatin; Dexrazoxane; Doxorubicin; Female; Humans; Infertility; Male; Methotrexate; Osteosarcoma | 2017 |
The cardioprotective effects of L-carnitine on rat cardiac injury, apoptosis, and oxidative stress caused by amethopterin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Carnitine; Catalase; Glutathione; Male; Malondialdehyde; Methotrexate; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Tumor Suppressor Protein p53 | 2016 |